Notification from the company CHAE
Document14 pages, a scan, not read yetOpen DFM’s file
Page 1
No text on this page.
Page 2
CHIMERA UCITS ICAV3-4 Upper Pembroke StreetDublin 2Ireland
Directors: Seif Fikry (Egypt), Jason Loveless (United Kingdom), Sherif Salem (Egypt), Syl O’Byrne and Feargal Dempsey (Chairman)
An umbrella fund with segregated liability between sub-funds
Registered in Ireland. Registered Number C188915 Registered Office: As above
HE219/001/AC#44967908.2Date: 12th December 2022
This document is important and should be read now. If you are unsure what action to take, please seek advice from your investment consultant or other professional adviser.
If you have sold or transferred all of your Shares in Chimera S&P UAE UCITS ETF (the “Fund”) a sub-fund of Chimera UCITS ICAV (the “ICAV”), please pass this letter at once to the purchaser or transferee or to the stockbroker, bank, or other agent you used to sell or transfer the Shares.
Unless defined differently in this letter, when we use capitalised terms they have the same meaning as in the latest prospectus of the Company and supplement in respect of the Fund dated 24
November 2021 (together, the “Prospectus”) You can get a copy of the Prospectus during normal business hours from the Administrator. Please note that the Central Bank of Ireland has not reviewed this letter.
Dear Shareholder,
We would like to notify you that effective 19th December 2022, S&P Dow Jones Indices, the Index Provider of S&P UAE BMI Liquid 20/35 Capped Index (the “Index”) of which the Chimera S&P UAE UCITS ETF (Share Classes A and D) currently tracks, will be capping the number of securities in the index to a maximum of 30 securities. Currently, the number of securities in the Index stands at 35 securities.
Therefore, the Chimera S&P UAE UCITS ETF Share Class A – Accumulating (CHAE) and Chimera S&P UAE UCITS ETF Share Class D – Income (CHAEIN) will be tracking the top 30 largest and most liquid securities in the UAE Markets from the 19th of December 2022. Apart from the change of number of securities and related modification of index construction methodology, no other changes are made to the methodology of the Index.
In addition, the investment policy for the Fund will be updated to reflect a minor adjustment in reset triggers for holdings in single issuers in line with the Index.
This letter has been sent by way of information. Should you have any questions in relation to this matter, you should either contact the ICAV at the above address or alternatively you should contact your investment consultant or any other professional adviser.
Yours sincerely,DirectorFor and on behalf ofChimera UCITS ICAV
Page 3
HE219/001/AC#34367749.28 1CHIMERA UCITS ICAV
An open-ended umbrella Irish collective asset-management vehicle with segregated liability between sub-funds formed in Ireland under the Irish Collective Asset-management Vehicles Act 2015
and authorised by the Central Bank as a UCITS pursuant to the Regulations.
SUPPLEMENTChimera S&P UAE UCITS ETFDated 19 December 2022
Page 4
HE219/001/AC#34367749.28 2Contents1. Important information ......................................................................................................... 32. Investment Objective ......................................................................................................... 43. Investment Policy .............................................................................................................. 44. Investment Restrictions of the Fund ................................................................................... 55. Risk Factors....................................................................................................................... 56. General information relating to the Fund ............................................................................ 57. Share classes .................................................................................................................... 78. Dividend Policy .................................................................................................................. 79. Fees and Expenses ........................................................................................................... 810. General Description of the Index........................................................................................ 811. Funds of the ICAV ........................................................................................................... 11
Page 5
HE219/001/AC#34367749.28 3
1. Important information
This Supplement contains information relating to the Chimera S&P UAE UCITS ETF (the “Fund”), a Fund of Chimera UCITS ICAV (the “ICAV”), an open-ended umbrella fund with segregated liability between Funds authorised by the Central Bank as a UCITS pursuant to the UCITS Regulations.
This Supplement forms part of and should be read in conjunction with the general description of the ICAV contained in the current Prospectus dated 24 November 2021 together with the most recent annual report and audited financial statements and if published after such report, a copy of the latest half-yearly report and unaudited financial statements. If you are in any doubt about the contents of this Supplement, you should consult your stockbroker, bank manager, solicitor, accountant or other independent financial adviser.
To the extent there is any inconsistency between this Supplement and the Prospectus, this Supplement shall prevail. Capitalised terms used and not defined herein shall have the meaning attributed to them in the Prospectus.
Investors should read and consider the section of the Prospectus headed “Risk Factors” before investing in the Fund.
The Fund may invest in emerging markets and accordingly investment in the Fund should not constitute a substantial portion of an investor's investment portfolio and may not be an appropriate for all investors.
Profile of a Typical Investor
Investment in the Fund may be appropriate for investors who have a medium-term investment horizon. The Fund is designed for investors who are willing to accept a medium to high level of volatility, including the possibility of a decline in the value of their investment and/or who are not seeking to invest to meet short term goals.
Responsibility
The Directors, whose names appear in the section of the Prospectus headed “Directory” accept responsibility for the information contained in the Prospectus and this Supplement. To the best of the knowledge and belief of the Directors (who have taken all reasonable care to ensure that such is the case) the information contained in the Prospectus and this Supplement is in accordance with the facts and does not omit anything likely to affect the import of the information.
General
As of the date of this Supplement, the ICAV does not have any loan capital (including term loans) outstanding or created but unissued and no outstanding mortgages, charges or other borrowings or indebtedness in the nature of borrowings, including bank overdrafts and liabilities under acceptances or acceptance credits, hire purchase or finance lease commitments, guarantees or other contingent liabilities.
The Fund's shares purchased on the Secondary Market cannot usually be sold directly back to the Fund. Investors must buy and sell shares on a Secondary Market with the assistance of an intermediary (e.g. a broker) and may incur fees for doing so. In addition, investors may pay more than the current Net Asset Value when buying shares and may receive less than the current Net Asset Value when selling them. There may be restrictions on certain classes of investor accessing shares on the Secondary Market. As at the date of this Supplement, Irish resident investors are not permitted to buy or sell shares of the Fund on the ADX or DFM.
Page 6
2 4
It should be noted that, in certain circumstances, dividends may be declared out of the capital of the Fund. Please refer to Section 8 - Dividend Policy below for further details. In any such cases, there is a greater risk that capital may be eroded and distribution will be achieved by foregoing the potential for future capital growth of your investment. This cycle may continue until all capital is depleted.
Application has been made to the DFM and the ADX and may be made to such other exchanges as the Directors may determine from time to time (the "Relevant Stock Exchanges") for listing and/or admission to trading of the shares issued and available to be issued on the main market of each of the Relevant Stock Exchanges. This Supplement and the Prospectus together comprise listing particulars for the purposes of trading on the main market of each of the Relevant Stock Exchanges. Please refer to Section 7 – Share Classes below for information on the listing venue of the Share Classes on issue.
2. Investment Objective
The Fund seeks to provide investors with a total return, taking into account capital and income returns, which reflects the return of an equity index called the S&P UAE BMI Liquid 20/35 Capped Index (the “Index”).
Further information on the components and selection criteria of the Index is set out below under "General Description of the Index".
There is no guarantee that the Fund will achieve its investment objective.
3. Investment Policy
In order to achieve its investment objective, the investment policy of the Fund is to invest 100% of its net assets in a portfolio of equity securities that consists of the equity securities of the Index. The Investment Manager may deviate from the 100% investment where it is, for whatever reason, not possible to buy and hold a particular Index security.
The Fund attempts to replicate, before fees and expenses, the performance of the Index. The Investment Manager will seek to do this by replicating so far as possible the investments in the Index by holding all of the securities comprising the Index in approximately the same proportion as its weighting in the Index. The Investment Manager will monitor the Fund's tracking accuracy on a daily basis and will seek to maintain an appropriate correlation between the return of the Index and the return of the Fund. It is expected, but not guaranteed that, the level of Tracking Difference shall not exceed 2% and the level of Tracking Error shall not exceed 1%, in normal market conditions.
The Index applies a capping screen of 20/35. This will mean that the Fund, through investing in the equity securities, may invest up to 20% of its net assets in a single security with the 20% limit being raised up to 35% in the case of a single issuer where justified by exceptional market conditions such as a material price movement impacting the weighting of that single component within the Index and necessitating a larger exposure. The index provider, Standard and Poor's, has put in place reset triggers at 33%/19% respectively to reset levels to ensure UCITS compliance. As such components which exceed exposures of 33% and 19% will be reset back to 33% and 19% at the next opportunity to ensure they do not hit the limits as set out in the UCITS Rules.
The Fund's Investments will be listed or traded on Regulated Markets worldwide and which are set out in the Prospectus but principally listed or traded on the DFM or the ADX.
Subject to the Investment Restrictions set out in the Prospectus and in circumstances where it is not possible (e.g. due to a market suspension of trading in a security) to acquire in the open market an equity or equities forming part of the Index, the Investment Manager may, on a temporary basis, use financial derivative instruments in the form of swaps (including total return swaps) for investment
Page 7
2 5
purposes in order to obtain economic exposure to the Index, a basket of Index securities or a particular Index security. Under normal market conditions, the Fund does not expect to use financial derivative instruments for investment purposes and so will not be leveraged as a result. Where financial derivative instruments are used, the Fund will use the commitment approach for the purpose of calculating global exposure. Accordingly, global exposure and leverage as a result of the Fund’s investment in financial derivative instruments shall not exceed 100% of the Net Asset Value of the Fund.
The Fund may enter into stock lending arrangements solely for the purposes of efficient portfolio management, subject to the conditions and within the limits set out in the Prospectus. The maximum proportion of the Net Asset Value of the Fund that can be subject to securities lending is 100%. The expected proportion of the Net Asset Value of the Fund that can be subject to securities lending is 100%.
4. Investment Restrictions of the Fund
The ICAV and the Fund adheres to the restrictions and requirements set out under the UCITS Regulations, as may be amended from time to time. The investment restrictions are set out in Schedule 3 to the Prospectus.
5. Risk Factors
The general risk factors set out under the section of the Prospectus headed "Risk Factors" apply to the Fund.
The risks described in the Prospectus should not be considered to be an exhaustive list of the risks which potential investors should consider before investing in the Fund. Potential investors should be aware that an investment in the Fund may be exposed to other risks from time to time.
6. General information relating to the Fund
6.1 General
Orders for Creation Units may be settled in cash, in-kind or in a combination of both, at the Manager’s discretion. Investors are referred to the procedures for subscribing and redeeming Creation Units in the section of the Prospectus headed “Application for subscriptions and redemptions”. Share Classes of the Fund available as at the date of this Supplement are detailed below in Section 7 -Share Classes.
6.2 Primary Market Dealing*
Base Currency AED
Business Day A business day in Ireland and a day on which either the DFM or the ADX as applicable is open for business or such other days as the Directors may from time to time determine and notify to Shareholders in advance.
Dealing Day Such Business Day or Business Days as the Directors, in conjunction with the Administrator, from time to time may determine and notify in advance to Shareholders, provided that, unless otherwise determined in respect of the Fund, each Business Day shall be a Dealing Day and provided further that in
Page 8
HE219/001/AC#34367749.28 6
any event there shall be at least two Dealing Days each month occurring at regular intervals.
Creation Unit 500,000 shares or such other minimum number that the Directors, in conjunction with the Administrator, from time to time may determine.
Initial Offer Periods The Initial Offer Period for Class A and Class D Shares is now closed. The Initial Offer Period for other Shares Classes shall continue to 19 June 2023 at 5:00pm (Gulf Standard Time) or such other time determined by the Directors in accordance with the requirements of the Central Bank.
SubscriptionSettlement Timefollowing the InitialOffer Period**
5 pm (Gulf Standard Time) on the second Business Day after the relevant Dealing Day or such other time determined by the Directors in accordance with the requirements of the Central Bank.
RedemptionSettlement Time***
5 pm (Gulf Standard Time) on the second Business Day after the relevant Dealing Day or such other time determined by the Directors in accordance with the requirements of the Central Bank.
Trade Cut-Off Time 3 pm (Gulf Standard Time) on the Dealing Day or such other time determined by the Directors for subscription or redemption in the Primary Market.
Distribution Date For any distributing shares, a date on which distributions are to be declared and which shall be a Business Day during June and December in each year,
as determined by the Investment Manager or paying agent, as appropriate.
Valuation Point 6.30 pm (Gulf Standard Time) on the Dealing Day or such other time determined by the Directors at which point the assets and liabilities of the Fund will be valued for the purposes of calculating the Net Asset Value.
Subscription Charge None.Redemption Charge None.
Duties and Charges Shares may be subscribed for on each Dealing Day at the Net Asset Value per share plus Duties and Charges (which, for the avoidance of doubt, may include Cash Transaction Fees #) up to a maximum of 3% of the Net Asset Value per share.
Shares may be redeemed on each Dealing Day at the Net Asset Value per share less Duties and Charges (which, for the avoidance of doubt, may include Cash Transaction Fees #) up to a maximum of 3% of the Net Asset Value per share.
Further details in relation to the application of Duties and Charges is set out in the Prospectus.
Minimum Viable FundSize
USD 20 million within 12 months of the Fund’s launch or such other period as may be determined by the Directors and notified to Shareholders in the Fund from time to time.
* All times are Gulf Standard Time (GST) unless otherwise specified.
Page 9
27
** In exceptional circumstances, earlier or later settlement times may be determined by the Directors or their delegate at their discretion with prior Shareholder notice and Administrator consent, where applicable, and will be done strictly on a best effort basis.
*** Applicable both to the time redemption proceeds are remitted by the Fund and the time by which shares of the Fund are to be delivered by the redeeming Shareholder. In exceptional circumstances, earlier or later settlement times may be determined by the Directors or their delegate at their discretion with prior Shareholder notice, where applicable, and will be done strictly on a best effort basis.
# Subject to the discretion of the Directors to waive such a fee.
7. Share Classes
Share Class ListingVenueClassCurrencyInitialOfferPrice*MinimumInitialSubscriptionMinimumRedemptionRequirementMinimumHoldingDividendPolicyClass A DubaiFinancialMarket
AED AED3.67500,000
shares500,000sharesN/A Accumulating
Class B USD USD1500,000
shares500,000sharesN/A Accumulating
Class C EUR EUR1500,000
shares500,000sharesN/A AccumulatingClass D Abu DhabiSecuritiesExchange
AED AED3.67500,000
shares500,000sharesN/A Distributing
Class E USD USD1500,000
shares500,000sharesN/A Distributing
Class F EUR EUR1500,000
shares500,000sharesN/A Distributing
* Note: The Initial Offer Price is expected to be approximately the amount specified in the above table. However, the actual Initial Offer Price will depend on the actual cost to the ICAV of purchasing the relevant Investments (please see definition of “Duties and Charges” in the Prospectus). Details of the Initial Offer Price will be available from the Administrator and at www.chimerainvestment.com.
The Fund may add additional Share Classes from time to time at the discretion of the Directors in accordance with the requirements of the Central Bank. A separate pool of assets will not be maintained for each Class within the Fund.
8. Dividend Policy
The Fund offers Classes of shares that accumulate income or pay regular dividends out of net income and realised and unrealised gains net of realised and unrealised losses attributable to the relevant Share Class. The distribution of dividends is not guaranteed and is subject to the sole discretion of the Directors.
Accumulating Classes
The Directors currently do not intend to declare or pay dividends with respect to the accumulating Classes of shares. Therefore, any net income and realised and unrealised gains net of realised and
Page 10
2 8
unrealised losses attributable to the shares of the accumulating Share Classes will be accumulated and reflected in their respective Net Asset Values per Share. Accordingly, investment in these Share Classes may not be suitable for investors seeking income returns for financial or tax planning purposes.
Distributing Classes
For the distributing Share Classes, the Directors may declare and pay dividends to the relevant Shareholders semi-annually on the Distribution Date (as set out in the table above). As the Index seeks to track the price performance of the companies contained within the Index and distributions made by those companies, dividends in respect of the distributing Share Classes will be calculated by reference to the embedded reinvested dividends within the Index during the relevant dividend period less taxes, including withholding taxes. As such, there is no guarantee that any dividend will be paid in respect of the distributing Classes. Dividends will be calculated so that any dividend declared will never be more than the excess performance of the total return performance of the Fund. The total return performance of the Fund is calculated by reference to the price return performance of the Index over the relevant calculation period (i.e. the relevant dividend period).
Such dividends shall be paid out of net income and realised and unrealised gains net of realised and unrealised losses attributable to the relevant Share Class of the Fund.
Please refer to the section headed “Dividend Policy” in the Prospectus for dividend payment details.
9. Fees and Expenses
9.1 Management Fee
The ICAV shall pay to the Manager out of the Fund’s assets an annual Management Fee of 1% of the Fund’s daily Net Asset Value. The Manager will retain a fee for its remuneration (in respect of the provision of management services and such other services as have been agreed with the Manager, including the provision of company secretarial services, MLRO services and the maintenance of the ICAV’s beneficial ownership register) out of the Management Fee (the “Manager’s Fee”) and any reasonable and properly vouched expenses (the “Manager’s Expenses”) as well as extraordinary expenses outside the ordinary course of business where agreed in advance with the ICAV (“Extraordinary Expenses”) and shall further discharge all fees and expenses related to the Fund, as detailed in the Prospectus under the section headed “Fees and Expenses”, out of the Management Fee.
The Manager shall pay the remainder of the Management Fee, if any, to the Investment Manager in consideration of the services provided by the Investment Manager pursuant to the Investment Management Agreement and Global Distribution Agreement. In the event that the Fund’s expenses as outlined in the Section 10.2 of the Prospectus exceed the Management Fee, the Investment Manager shall discharge any such expenses out of its own assets.
9.2 Establishment Expenses
The fees and expenses relating to the establishment and approval of the Fund, including the fees of the ICAV’s professional advisers, the fees and expenses incurred with respect to registering the shares of the Fund for sale in various markets, and the expenses associated with the issue of shares, including the costs incurred in connection with the preparation and publication of this Supplement, and all legal and printing costs will be borne by the Investment Manager.
9.3 Rebalancing costs
The Fund may charge rebalancing costs (such as brokerage, exchange trading costs or other fees, charges, interest, taxes or levies incurred in connection with acquiring or disposing of investments) to the capital of the Fund. This will have the effect of lowering the capital value of a Shareholders investment.
Additional fees and operating expenses of the ICAV are set out in detail under the section of the Prospectus headed “Fees and Expenses”.
Page 11
2 9
10. General Description of the Index
10.1 Index Description
The Index is a modified weighted total return index measuring the performance of 30 of the largest constituents of the S&P UAE BMI Index. The S&P UAE BMI Index is a leading benchmark for tracking performance of UAE companies and as of 31 October 2022 comprised 35 securities.
10.2 Index Eligibility
The Index is comprised of the constituents of the S&P UAE BMI Index that meet the following eligibility requirements: (i) companies must have no more than ten non-trading days over the previous quarter; and (ii) have a three-month average daily value traded of at least US$500,000 for at least one of the two quarterly periods preceding the rebalancing reference date. Further details on Index construction are set out in Section 10.3 below.
Details and additional information on the Index may be found at:
https://www.spglobal.com/spdji/en/indices/equity/sp-uae-bmi-liquid-20-35-capped-index/#overview For details of the exact composition, including weightings, of the portfolio of the Fund will be published daily and can be found at: www.chimerainvestment.com.
The Index follows a three-month average daily traded value of >= $500,000. Stocks failing to meet this level will drop out of the Index once this liquidity screen fails to be met for two consecutive calendar quarters.
Frequency of Rebalance: Quarterly as per Standard and Poor's (“S&P”) policy. The costs of rebalancing the Fund's investments, which are not expect to be significant, will be borne by the relevant Fund.
Index type: Total Return and Price ReturnIndex currency: USD and AEDBase date for S&P UAE BMI Index: 31 December 2008
10.3 Index Construction
At each rebalancing, eligible stocks will be ranked in the underlying index by 6 month Average Daily Value Traded (“ADVT”), selecting a target constituent count of 30 stocks for inclusion in the Index, subject to the following selection buffer:
(i) all stocks ranked in the top 24 are automatically selected;
(ii) current constituents in the top 36 are selected until the target constituent count is reached;
(iii) if after step (ii), the target constituent count is still not met, the largest non-constituent, by free-float market capitalization (“FMC”), is selected and added to the Index. This process continues iteratively until the target constituent count is met.
(iv) If fewer than 30 stocks are eligible, all eligible stocks are selected, and the target constituent count is not met.
10.4 Index Additions and Deletions
Constituents removed from the underlying index are removed from the Index simultaneously. If a constituent is deleted between rebalancings, the next largest stock, by 6 month ADVT, from the
Page 12
2 10
reserve list is added as a replacement in order to maintain a constituent count of 30. Constituents added under the replacement rule are added at the stock’s float-adjusted market capitalization weight.
10.5 Index Weighting
The Index applies a UCITS capping screen of 20/35. This is to allow the Fund, whose policy is to replicate the Index, to invest up to 20% of its net assets in individual securities with the 20% limit being raised up to 35% in the case of a single issuer where justified by exceptional market conditions which may include the dominance of a particular issuer in the relevant market. The Index provider, S&P, has set triggers in place of at 33%/19% respectively to reset levels to ensure UCITS compliance at all times. At each rebalancing, the Index is capped market capitalization weighted, with constituents’ FMC weights capped by the following constraints, if necessary:
(i) If the largest constituent’s weight exceeds 33%, that constituent is capped at 33%; and (ii) If the weight of any other constituent is greater than 19%, that constituent is capped at 19%.
Any excess weight due to capping is proportionally redistributed to uncapped constituents. The process continues iteratively until both constraints are satisfied.
The Index methodology setting out the weighted and capping methodology can be found in the following link, under S&P UAE BMI Liquid 20/35 Capped Index:
https://www.spglobal.com/spdji/en/indices/equity/sp-uae-bmi-liquid-20-35-capped-index/#overview 10.6 Methodology
The S&P index upon which the Index is based will be maintained in accordance with S&P's present methodology and any changes, adjustments, enhancements or other modifications to the S&P Index shall be at S&P's full discretion. The UAE companies are chosen in accordance with the S&P Dow Jones country classification methodology which can be found at:
https://www.spglobal.com/spdji/en/indices/equity/sp-uae-bmi-liquid-20-35-capped-index/#overview
10.7 Trading Volume
At the annual reconstitution, stocks must have an annual dollar value traded of at least US$ 50 million, over the previous 12 months, to be added to the S&P Global BMI Index. Index constituents are excluded if their liquidity falls below US$ 35 million during the previous 12 months.
10.8 Index calculations
The Index is calculated end-of-day, using the divisor methodology used in all S&P Dow Jones Indices' equity indices, and are calculated six days a week, Sunday through Friday.
The Fund is subject to index tracking risk, which is the risk that its returns may not track exactly those of the Index. Tracking Difference and Tracking Error may result from an inability to hold the exact constituents of the Index, for example where there are local market trading restrictions, and/or where the UCITS Regulations limit exposure to the constituents of the Index.
Page 13
2 11DisclaimersTHE DIRECTORS OF THE ICAV, THE MANAGER, THE INVESTMENT MANAGER AND THE INDEXPROVIDER TOGETHER THE "RESPONSIBLE PARTIES" DO NOT GUARANTEE THE ACCURACYAND/OR THE COMPLETENESS OF ANY DESCRIPTION RELATING TO THE INDEX OR ANY DATAINCLUDED THEREIN AND THE RESPONSIBLE PARTIES SHALL HAVE NO LIABILITY FOR ANYERRORS, OMISSIONS, OR INTERRUPTIONS THEREIN. THE RESPONSIBLE PARTIES MAKE NOWARRANTY, EXPRESS OR IMPLIED, AS TO THE FUND, TO ANY SHAREHOLDER IN THE FUND,OR TO ANY OTHER PERSON OR ENTITY IN RESPECT OF THE INDEX DESCRIBED HEREIN.THE RESPONSIBLE PARTIES MAKE NO EXPRESS OR IMPLIED WARRANTIES, ANDEXPRESSLY DISCLAIM ALL WARRANTIES OF MERCHANTABILITY OR FITNESS FOR APARTICULAR PURPOSE OR USE WITH RESPECT TO THE INDEX OR STRATEGY OR ANY DATAINCLUDED HEREIN. WITHOUT LIMITING ANY OF THE FOREGOING, IN NO EVENT SHALL THERESPONSIBLE PARTIES HAVE ANY LIABILITY FOR ANY SPECIAL, PUNITIVE, INDIRECT, ORCONSEQUENTIAL DAMAGES OR FOR ANY LOST PROFITS, EVEN IF NOTIFIED OF THEPOSSIBILITY OF SUCH DAMAGES.STANDARD & POOR'S, S&P, S&P 500® ARE REGISTERED TRADEMARKS OF S&P AND DOWJONES IS A REGISTERED TRADEMARK OF DOW JONES TRADEMARK HOLDINGS LLC(“DOW JONES”). THE TRADEMARKS HAVE BEEN LICENSED TO S&P DOW JONES INDICESLLC AND HAVE BEEN SUBLICENSED FOR USE FOR CERTAIN PURPOSES BY CHIMERACAPITAL LIMITED (“CHIMERA”) TO THE ICAV. THE “DEFINED INDEX SERIES” IS A PRODUCTOF S&P DOW JONES INDICES LLC, AND HAS BEEN LICENSED FOR USE BY CHIMERA. THEFUNDS ARE NOT SPONSORED, ENDORSED, SOLD OR PROMOTED BY S&P DOW JONESINDICES LLC, DOW JONES, S&P, OR ANY OF THEIR RESPECTIVE AFFILIATES(COLLECTIVELY, “S&P DOW JONES INDICES”). S&P DOW JONES INDICES MAKES NOREPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, TO THE SHAREHOLDERS ORANY MEMBER OF THE PUBLIC REGARDING THE ADVISABILITY OF INVESTING INSECURITIES GENERALLY OR IN THE FUNDS PARTICULARLY OR THE ABILITY OF ANY OFTHE DEFINED INDEX SERIES TO TRACK GENERAL MARKET PERFORMANCE. S&P DOWJONES INDICES ONLY RELATIONSHIP TO CHIMERA WITH RESPECT TO THE DEFINEDINDEX SERIES IS THE LICENSING OF THE INDICES AND CERTAIN TRADEMARKS, SERVICEMARKS AND/OR TRADE NAMES OF S&P DOW JONES INDICES. THE DEFINED INDEXSERIES IS DETERMINED, COMPOSED AND CALCULATED BY S&P DOW JONES INDICESWITHOUT REGARD TO CHIMERA OR THE FUNDS. S&P DOW JONES INDICES HAS NOOBLIGATION TO TAKE THE NEEDS OF CHIMERA OR THE FUNDS INTO CONSIDERATION INDETERMINING, COMPOSING OR CALCULATING THE DEFINED INDEX SERIES. S&P DOWJONES INDICES IS NOT RESPONSIBLE FOR AND HAS NOT PARTICIPATED IN THEDETERMINATION OF THE SHARE PRICES, AND AMOUNT OF SHARE OF THE FUNDS ORTHE TIMING OF THE ISSUANCE OR SALE OF SHARE OF THE FUNDS OR IN THEDETERMINATION OR CALCULATION OF THE EQUATION BY WHICH THE FUNDS ARE TO BEISSUED. S&P DOW JONES INDICES HAS NO OBLIGATION OR LIABILITY IN CONNECTIONWITH THE ADMINISTRATION, MARKETING OR TRADING OF THE FUNDS. THERE IS NOASSURANCE THAT INVESTMENT PRODUCTS BASED ON THE DEFINED INDEX SERIES WILLACCURATELY TRACK INDEX PERFORMANCE OR PROVIDE POSITIVE INVESTMENTRETURNS. S&P DOW JONES INDICES LLC IS NOT AN INVESTMENT ADVISOR. INCLUSIONOF A SECURITY WITHIN AN INDEX IS NOT A RECOMMENDATION BY S&P DOW JONESINDICES TO BUY, SELL, OR HOLD SUCH SECURITY, NOR IS IT CONSIDERED TO BEINVESTMENT ADVICE.S&P DOW JONES INDICES DOES NOT GUARANTEE THE ADEQUACY, ACCURACY,TIMELINESS AND/OR THE COMPLETENESS OF THE DEFINED INDEX SERIES OR ANY DATARELATED THERETO OR ANY COMMUNICATION, INCLUDING BUT NOT LIMITED TO, ORALOR WRITTEN COMMUNICATION (INCLUDING ELECTRONIC COMMUNICATIONS) WITHRESPECT THERETO. S&P DOW JONES INDICES SHALL NOT BE SUBJECT TO ANYDAMAGES OR LIABILITY FOR ANY ERRORS, OMISSIONS, OR DELAYS THEREIN. S&P DOWJONES INDICES MAKES NO EXPRESS OR IMPLIED WARRANTIES, AND EXPRESSLY
Page 14
2 12DISCLAIMS ALL WARRANTIES, OF MERCHANTABILITY OR FITNESS FOR A PARTICULARPURPOSE OR USE OR AS TO RESULTS TO BE OBTAINED BY CHIMERA, OWNERS OF THEFUNDS, OR ANY OTHER PERSON OR ENTITY FROM THE USE OF THE DEFINED INDEXSERIES OR WITH RESPECT TO ANY DATA RELATED THERETO. WITHOUT LIMITING ANYOF THE FOREGOING, IN NO EVENT WHATSOEVER SHALL S&P DOW JONES INDICES BELIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL, PUNITIVE, OR CONSEQUENTIALDAMAGES INCLUDING BUT NOT LIMITED TO, LOSS OF PROFITS, TRADING LOSSES, LOSTTIME OR GOODWILL, EVEN IF THEY HAVE BEEN ADVISED OF THE POSSIBLITY OF SUCHDAMAGES, WHETHER IN CONTRACT, TORT, STRICT LIABILITY, OR OTHERWISE. THEREARE NO THIRD-PARTY BENEFICIARIES OF ANY AGREEMENTS OR ARRANGEMENTSBETWEEN S&P DOW JONES INDICES AND CHIMERA, OTHER THAN THE LICENSORS OFS&P DOW JONES INDICES.
11. Funds of the ICAV
There are currently no other Funds of the ICAV in existence. Additional Funds of the ICAV may be added in the future with the prior approval of the Central Bank.